Investingating the Effect of Individual Meaning_ centered psychotherapy ( IMCP) on Resilience and Death anxiety in patients with Leukemia

Investingating the Effect of virtual Individual Meaning_ centered psychotherapy ( IMCP) on Resilience and Death anxiety in patients with Leukemia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20260427069184N1

Enrollment

Registered

2026-04-29

Start date

2026-05-20

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia.

Interventions

Intervention 1: Intervention group: The intervention used in this study is individual meaning-centered psychotherapy delivered virtually, designed based on Breitbart’s meaning-centered psychotherapy p

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 18 years or older. Physical stability and ability to participate in virtual meaning-centered therapy sessions, as determined by the treatment team Ability to communicate verbally and in writing Having at least a minimum level of literacy to understand the content of the sessions and complete the study questionnaires Access to a mobile phone or digital device for the intervention (voice calls, voice messages, or text messages). Stable internet access and use of at least one virtual messenger capable of receiving and playing audio and video files related to the intervention (such as WhatsApp, Telegram, Eitaa, Bale, Soroush, or similar applications).

Exclusion criteria

Exclusion criteria: Presence of diagnosed severe psychiatric disorders. Presence of other types of cancer, as determined by a physician. Significant medical conditions or physical instability that prevent participation in the intervention. Prior history of meaning-centered psychotherapy or any other psychological intervention.

Design outcomes

Primary

Measure	Time frame
Death anxiety score in patients with leukemia measured by the Templer Death Anxiety Scale with a total score range of 0 to 15Resilience score in patients with leukemia measured by the Connor–Davidson Resilience Scale with a total score range of 0 to 100. Timepoint: Baseline, immediately after completion of the intervention, and one month after completion of the intervention. Method of measurement: Death anxiety is measured using the Templer Death Anxiety Scale consisting of 15 yes or no items with a total score range of 0 to 15; higher scores indicate greater death anxiety.Resilience is measured using the Connor–Davidson Resilience Scale consisting of 25 items rated on a 0 to 4 Likert scale with a total score range of 0 to 100; higher scores indicate greater resilience.	—

Measure

Time frame

Death anxiety score in patients with leukemia measured by the Templer Death Anxiety Scale with a total score range of 0 to 15Resilience score in patients with leukemia measured by the Connor–Davidson Resilience Scale with a total score range of 0 to 100. Timepoint: Baseline, immediately after completion of the intervention, and one month after completion of the intervention. Method of measurement: Death anxiety is measured using the Templer Death Anxiety Scale consisting of 15 yes or no items with a total score range of 0 to 15; higher scores indicate greater death anxiety.Resilience is measured using the Connor–Davidson Resilience Scale consisting of 25 items rated on a 0 to 4 Likert scale with a total score range of 0 to 100; higher scores indicate greater resilience.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYasaman.Sheibeh

Ahvaz University of Medical Sciences

sheibeh.yasaman@gmail.com+98 61 3323 5097

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026